(Q46079295)

19 December 2017

title

Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes (English)

1 reference

19 December 2017

0 references

5

Leon J Thal

1 reference

19 December 2017

author name string

Rochelle E Tractenberg

1

1 reference

19 December 2017

Myron F Weiner

2

1 reference

19 December 2017

Marian B Patterson

3

1 reference

19 December 2017

Anthony Gamst

4

1 reference

19 December 2017

publication date

1 January 2002

1 reference

19 December 2017

Journal of Geriatric Psychiatry and Neurology

published in

1 reference

19 December 2017

volume

15

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

110-117

1 reference

19 December 2017

Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Gender differences in the behavioral manifestations of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

The course of psychopathologic features in mild to moderate Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Prevalence of symptoms on the CERAD behavior rating scale for dementia in normal elderly subjects and Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

A 2-year follow-up of behavioural and psychological symptoms in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Relation of cognitive status and abnormal behaviors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Differential neuropsychiatric symptom responses to tacrine in Alzheimer's disease: relationship to dementia severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

Executive cognitive impairment: a novel perspective on dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198870201500210

10.1177/089198870201500210

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017